Janux Therapeutics

This early-stage study tests a new drug, JANX007, in men with metastatic castration-resistant prostate cancer that has worsened after other treatments. The main goals are to check safety and find the right dose. About 272 participants will receive the drug to see if it can help c…

This early-stage study tests a new drug, JANX014, in 43 men with a hard-to-treat type of prostate cancer that has spread and stopped responding to standard hormone therapy and chemotherapy. The main goals are to check the drug's safety and find the right dose, while also looking …

This early-phase trial tests a new drug called JANX008 in adults with advanced solid tumors (like lung, kidney, breast, or colorectal cancer) that have stopped responding to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shri…

This early-stage study tests a new drug called JANX011 in 60 healthy adults to see if it is safe and how the body processes it. The goal is to gather information that could help treat autoimmune diseases in the future. Participants receive one or more doses and are monitored clos…